​​” Optimising CRSwNP Management A six-month Randomised Controlled Trial of Mepolizumab with or without FESS”

Assessment Committee:
Professor Per Cayé-Thomasen (Chairperson)
Professor Johan Hellgren
Professor Wytske Fokkens

Supervisors:
Clinical Professor Vibeke Backer
Clinical Associate Professor Kasper Aanæs